When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
VTVT - vTv Therapeutics' TTP399 successful in mid-stage type 1 diabetes study
vTv Therapeutics Inc.
VTv Therapeutics (NASDAQ:VTVT) is up 45% premarket on the heels of results from the Phase 2 Simplici-T1 study evaluating TTP399 as an adjunct to insulin therapy in adults with type 1 diabetes.
More news on: vTv Therapeutics Inc., Healthcare stocks news,